Efficacy of Exenatide Plus Pioglitazone Vs Basal/Bolus Insulin in T2DM Patients With Very High HbA1c
Author:
Affiliation:
1. Diabetes Research, Academic Health System, Hamad General Hospital, Doha, Qatar; and
2. Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229
Publisher
The Endocrine Society
Subject
Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism
Link
http://academic.oup.com/jcem/article-pdf/102/7/2162/18171279/jc.2016-3423.pdf
Reference33 articles.
1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;The Diabetes Control and Complications Trial Research Group;N Engl J Med,1993
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998
3. Glycemic control and prevention of retinopathy in Japanese NIDDM patients. A 10-year follow-up study;Nakagami;Diabetes Care,1997
4. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus;Klein;Ann Intern Med,1996
5. β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment;Halban;Diabetes Care,2014
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SGLT2 inhibitors: cardiorenal metabolic drugs for the ages;Journal of Clinical Investigation;2024-03-01
2. A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c ≥9–15%: DUAL HIGH Trial;Diabetes Care;2023-07-17
3. Personalized approach for type 2 diabetes pharmacotherapy: where are we and where do we need to be?;Expert Opinion on Pharmacotherapy;2021-08-26
4. Insulin secretion is a strong predictor for need of insulin therapy in patients with new‐onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study;Diabetes, Obesity and Metabolism;2021-05-06
5. Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT;Diabetes Care;2020-12-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3